Whole-genome sequencing and health insurance

By Daryl Spinner, PhD, MBA

In the realm of genetic testing, insurance payers have been reluctant to recognize that there is a method of testing that gives physicians over 99% of the information that they need to solve current or even future medical puzzles related to genetics.

When evaluating insurance policies, it’s important to know that whole-genome sequencing (WGS) offers the most comprehensive testing available providing granular, actionable data from an individual’s DNA to diagnose and effectively treat many inherited disorders, including inherited cancers.

Read the full article at ThinkAdvisor.